Sartorius Aktiengesellschaft (FRA:SRT4)

Market Cap	15.39B +22.6%
Revenue (ttm)	3.58B +3.3%
Net Income	196.10M +88.4%
EPS	n/a
Shares Out	n/a
PE Ratio	78.49
Forward PE	39.10
Dividend	0.08 (0.21%)
Ex-Dividend Date	Mar 30, 2026

Volume	n/a
Open	38.20
Previous Close	37.60
Day's Range	38.20 - 38.20
52-Week Range	30.80 - 40.20
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 22, 2026

About FRA:SRT4

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture...

• Industry: Laboratory Analytical Instruments
• Founded: 1870
• Employees: 14,279
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: SRT4

Financial Performance

In 2025, FRA:SRT4's revenue was 3.54 billion, an increase of 4.66% compared to the previous year's 3.38 billion. Earnings were 154.90 million, an increase of 84.40%.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Sep 18, 2026

Data Sources Report a data error